retatrutide phase 2 trial results weight loss just delivered the first top-line 3 for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Eli Lilly's Retatrutide Phase 3

Lipohypertrophy can change your pharmacokinetic profile unpredictably, making timing optimization pointless because you no longer know how fast the drug is reaching your bloodstream

Provider collaboration: Precertification of Vida Health as a responsible prescriber streamlines the process and ensures only evidence-based and cost-effective prescriptions are provided

Direct Comparison Studies While large head-to-head trials specifically comparing these medications for weight loss are limited, the SUSTAIN 10 trial compared them for diabetes: SUSTAIN 10 results: Semaglutide 1mg vs

Some patients alternate between the two

All brands and products mentioned work identically for both medications

Injection site reactions Injection site reactions are typically mild and temporary side effects of retatrutide